Skip to content

Efficacy of Midazolam on sedation

Comparing sedative effect of Midazolam injection by jet injector with intravenous Midazolam for diagnostic procedures in 1 to 6 years old children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201510018640N2
Enrollment
30
Registered
2016-03-23
Start date
2016-05-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric trauma. Injury nonspecified

Interventions

Intervention 1: In the intervention group Midazolam is administered 0.2 mg/kg subcutaneously with the jet injector. If the patient doesn't inter to the sedation phase, injection is repeated 20 min aft
Treatment - Drugs
In the intervention group Midazolam is administered 0.2 mg/kg subcutaneously with the jet injector. If the patient doesn't inter to the sedation phase, injection is repeated 20 min after the first inj
In the control group Midazolam is administered 0.1 mg/kg intravenously through a peripheral catheter. If the patient doesn't inter to the sedation phase, the administered dose is repeated every 3 min

Sponsors

Shahid Sadoughi University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: Children 1-6 years old coming to Emergency Department due to trauma, requiring sedation for diagnostic procedures are included in the study. Those patients with one or more of the fallowing conditions are excluded: Unstable vital signs; Decreased level of consciousness; Anticonvulsants drug use; Hypersensitivity to Midazolam; Reluctance to participate in the study; Patients with moderate to severe (distracting) pain.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Success rate of sedation for prosedure. Timepoint: Emediately after the procedure. Method of measurement: Sedation scale (level 0: conscious- level 1: silence- level 2: drowsiness- level 3: snoozing- level 4: deep sleep).

Secondary

MeasureTime frame
Emergency department stay time. Timepoint: Before and after the intervention. Method of measurement: Time interval between admission and discharge from the emergency department.;Time to appropriate sedation. Timepoint: After the intervention. Method of measurement: Time interval between drug administration to level one of sedation.;Time to complete arrosal. Timepoint: After the intervention. Method of measurement: Time interval between drug administration to complete arrosal.;Failure of sedation. Timepoint: After the intervention. Method of measurement: Not reaching to the level one of sedation after administrating the maximum determined dose.;Physician satisfaction from sedation. Timepoint: After the intervention. Method of measurement: Five choice likert scale.;Parents satisfaction from sedation. Timepoint: After the intervention. Method of measurement: Five point likert scale.;Rate of complications. Timepoint: After the intervention. Method of measurement: Assessment of sign and symptoms of sedation complication.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Hajimaghsoudi

Shahid Sadoughi University of Medical Scienses

hajimaghsoudi@gmail.com+98 35 3626 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026